Medical News

RSS

EMA agrees to Swedish Orphan Biovitrum, Biogen Idec's pediatric rFIXFc trial in hemophilia

Biogen Idec and Swedish Orphan Biovitrum today announced that the European Medicines Agency's Pediatric Committee has adopted an opinion agreeing to the pediatric investigational plan for the companies' long-lasting, fully-recombinant Factor IX Fc fusion protein.

9 May 2011

Psychotherapeutic treatment can cure cyclothymic disorder

In the current issue of Psychotherapy and Psychosomatics a group of Italian investigators headed by Giovanni Fava published a randomized controlled trial on psychotherapeutic treatment of cyclothymic disorder, a disturbance that is characterized by rapid alternation of mood swings.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Epigenomics presents Septin9 blood test study data in colorectal cancer at DDW 2011

Epigenomics AG, the cancer molecular diagnostics company, reports that Dr. Uri Ladabaum, Associate Professor in the Department of Gastroenterology and Hepatology at the School of Medicine of Stanford University, has presented the results of a health economic analysis of potential future colorectal cancer screening with Septin9 blood tests at the ongoing Digestive Disease Week 2011.

9 May 2011

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.

9 May 2011

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Heptares Therapeutics today announced it has signed an exclusive option agreement with Shire Pharmaceuticals for a novel adenosine A2A antagonist discovered by Heptares and currently in preclinical development.

9 May 2011

Preliminary data from ST-DETECT Trial using EGM signals in ICDs presented at SCAI meeting

New data presented today at the Society for Cardiovascular Angiography and Interventions Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting.

9 May 2011

Young new nurses more likely to follow latest VG site advice to administer intramuscular injections

Seven out of ten hospital nurses who took part in a Canadian study used the dorsogluteal buttock site to administer intramuscular injections - despite the potential risks of sciatic nerve injury - with only 14% using the ventrogluteal hip site recommended by the nursing literature.

9 May 2011

Merrimack acquires development and commercialization rights to MM-398 in Europe, Asia

Merrimack Pharmaceuticals, Inc. and PharmaEngine, Inc. today announced the signing of an agreement under which Merrimack has acquired the rights to develop and commercialize MM-398 in Europe and Asia.

9 May 2011

Philips, IBA enter agreement to establish proton therapy center for patients

IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, today announced they have entered into an agreement to create state of the art patient-centric proton therapy centers.

From Philips Healthcare 9 May 2011

Researchers use computer screens to detect how human brain performs visual search

In the wild, mammals survive because they can see and evade predators lurking in the shadowy bushes. That ability translates to the human world. Transportation Security Administration screeners can pick out dangerous objects in an image of our messy and stuffed suitcases. We get out of the house every morning because we find our car keys on that cluttered shelf next to the door.

9 May 2011

Diamyd Medical announces European Phase III study results in type 1 diabetes

Diamyd Medical reports that results from its European Phase III study with the antigen-based therapy Diamyd did not meet the primary efficacy endpoint of preserving beta cell function at 15 months, as measured by meal stimulated C-peptide, in newly diagnosed type 1 diabetes patients.

9 May 2011

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.

9 May 2011

Season-of-birth factors can cause celiac disease in Massachusetts children

Celiac disease is more common among Massachusetts children born in the spring or summer, and this higher incidence could be related to the intersection of key seasonal and environmental factors, according to researchers at the Massachusetts General Hospital for Children.

9 May 2011

New international project to create more mutant genes, address shortage of Cre resources

Local scientists are now part of an International team compiling an enormous bank of resources for research into the functions of all known genes. The development of these biological resources will eventually allow scientists to know how the human genome behaves in health and disease.

9 May 2011

Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio

In today's highly competitive marketplace, bio-pharmaceutical companies often look to expand their product portfolios in the same indication. This "double-dipping" can result in a new brand gaining more profitability at the expense of a more established brand.

9 May 2011

CMS outlines two different ways to revise Medicare payment system for skilled nursing care

In conjunction with a hearing today before the U.S. House Committee on Education and the Workforce in which Health and Human Services Secretary Kathleen Sebelius testified about the "Policies and Priorities of the U.S. Department of Health and Human Services," the Alliance for Quality Nursing Home Care underscored the importance of provider - Department collaboration in recalibrating the recently implemented Medicare payment system for skilled nursing facility care.

9 May 2011

Innovative detection practices may prevent liver diseases

Research being presented at Digestive Disease Week- shows that screening individuals for hepatitis C based on age instead of conventional risk factors may help increase detection rates as well as prevent liver disease.

9 May 2011

Researchers analyze gene expression profiles to understand molecular mechanisms behind various diseases

Over the past decades, researchers seeking to understand molecular mechanisms underlying various diseases, notably cancer, have taken advantage of DNA microarrays to interrogate tissues specimen of patients for the expression status of thousands of genes at once.

9 May 2011

Retirees face big challenges on health costs

A survey by Sun Life Financial, released this week, found that 92 percent of workers said they don't know how much their health care will cost in retirement or vastly underestimated the amount. Only 8 percent were in the correct range, estimating costs of $200,000 or more. In fact, a 65-year-old couple retiring this year will need $230,000, on average, to cover medical expenses in retirement, according to a separate Fidelity Investments study released in March.

9 May 2011

Medical News

EMA agrees to Swedish Orphan Biovitrum, Biogen Idec's pediatric rFIXFc trial in hemophilia

Psychotherapeutic treatment can cure cyclothymic disorder

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Epigenomics presents Septin9 blood test study data in colorectal cancer at DDW 2011

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Preliminary data from ST-DETECT Trial using EGM signals in ICDs presented at SCAI meeting

Young new nurses more likely to follow latest VG site advice to administer intramuscular injections

Merrimack acquires development and commercialization rights to MM-398 in Europe, Asia

Philips, IBA enter agreement to establish proton therapy center for patients

Researchers use computer screens to detect how human brain performs visual search

Diamyd Medical announces European Phase III study results in type 1 diabetes

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Season-of-birth factors can cause celiac disease in Massachusetts children

New international project to create more mutant genes, address shortage of Cre resources

Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio

CMS outlines two different ways to revise Medicare payment system for skilled nursing care

Innovative detection practices may prevent liver diseases

Researchers analyze gene expression profiles to understand molecular mechanisms behind various diseases

Retirees face big challenges on health costs

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News